FSGS

Clinical trials for FSGS explained in plain language.

Never miss a new study

Get alerted when new FSGS trials appear

Sign up with your email to follow new studies for FSGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 1 Completed 1

Can a drug stop kidney disease from returning after transplant?

Disease control Completed

This study tested whether the drug Acthar can prevent focal segmental glomerulosclerosis (FSGS) from coming back in people who receive a kidney transplant. Fifteen adults with FSGS and advanced kidney disease took part. Researchers measured how many had FSGS return by looking at …

Matched conditions: FSGS

Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control

Last updated Jul 02, 2026 03:00 UTC

FSGS

Get alerted when new FSGS trials appear

Can a drug stop kidney disease from returning after transplant?